| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721890 | Digestive and Liver Disease | 2018 | 5 Pages |
Abstract
In PADC, fractionated SBRT dose schedules near 30â¯Gy may strike the best balance of local control and bowel toxicity. More work is required to integrate pancreatic SBRT with modern systemic therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Raphaël Jumeau, Guila Delouya, David Roberge, David Donath, Dominic Béliveau-Nadeau, Marie-Pierre Campeau,